“DETECTABLE IN-BLOOD BRCA1 METHYLATION AS A BIOMARKER OF BREAST CANCER PREDISPOSITION” (2026) International Journal of Innovative Technologies in Social Science, 1(1(49). doi:10.31435/ijitss.1(49).2026.4552.